Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
about
Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?Recent advances in the management of lymphangioleiomyomatosis.
P2860
Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Pulmonary hypertension in lymp ...... capacity as a screening method
@ast
Pulmonary hypertension in lymp ...... capacity as a screening method
@en
Pulmonary hypertension in lymp ...... apacity as a screening method.
@nl
type
label
Pulmonary hypertension in lymp ...... capacity as a screening method
@ast
Pulmonary hypertension in lymp ...... capacity as a screening method
@en
Pulmonary hypertension in lymp ...... apacity as a screening method.
@nl
prefLabel
Pulmonary hypertension in lymp ...... capacity as a screening method
@ast
Pulmonary hypertension in lymp ...... capacity as a screening method
@en
Pulmonary hypertension in lymp ...... apacity as a screening method.
@nl
P2093
P2860
P50
P1476
Pulmonary hypertension in lymp ...... capacity as a screening method
@en
P2093
Carolina S G Freitas
Gláucia I Heiden
Juliana Barbosa Sobral
Mariana S Araujo
Ronaldo A Kairalla
P2860
P2888
P356
10.1186/S13023-017-0626-0
P577
2017-04-20T00:00:00Z
P6179
1084954478